ArticleFrontiers in pharmacology2023
A universal lesion detection method based on partially supervised learning.
Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Partially supervised learning (PSL) is urgently necessary to explore to construct an efficient universal lesion detection (ULD) segmentation model. An annotated dataset is crucial but hard to acquire because of too many Computed tomography (CT) images and the lack of professionals in computer-aided detection/diagnosis (CADe/CADx). To address this problem, we propose a novel loss function to reduce the proportion of negative anchors which is extremely likely to classify the lesion area (positive samples) as a negative bounding box, further leading to an unexpected performance. Before calculating loss, we generate a mask to intentionally choose fewer negative anchors which will backward wrongful loss to the network. During the process of loss calculation, we set a parameter to reduce the proportion of negative samples, and it significantly reduces the adverse effect of misclassification on the model. Our experiments are implemented in a 3D framework by feeding a partially annotated dataset named DeepLesion, a large-scale public dataset for universal lesion detection from CT. We implement a lot of experiments to choose the most suitable parameter, and the result shows that the proposed method has greatly improved the performance of a ULD detector. Our code can be obtained at https://github.com/PLuld0/PLuldl.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.